Literature DB >> 6683983

Genetics of platelet MAO activity in discordant schizophrenic and normal twins.

M A Reveley, A M Reveley, C A Clifford, R M Murray.   

Abstract

Platelet monoamine oxidase (MAO) activity was compared in four age and sex-matched groups: monozygotic (MZ) twins discordant for schizophrenia, normal MZ twins, normal dizygotic (DZ) twins and unrelated individuals. Among the twin groups, schizophrenic and normal there was a remarkably consistent degree of genetic control amounting to 70-80 per cent of the variation in activity. The mean platelet MAO activity of the schizophrenic twins was significantly lower than that of controls, but not than that of their psychiatrically well, neuroleptic-free cotwins; indeed the correlation for the MZ twins discordant for schizophrenia was almost exactly the same as that for the normal MZs. Thus, lower platelet MAO activity in schizophrenia, where it is found, is genetically modulated and not the result of the illness or its treatment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6683983     DOI: 10.1192/bjp.142.6.560

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  7 in total

1.  Relationship between platelet MAO activity and concentrations of 5-HIAA and HVA in cerebrospinal fluid in chronic pain patients.

Authors:  L von Knorring; L Oreland; J Häggendal; T Magnusson; B Almay; F Johansson
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

2.  Platelet MAO in patients with idiopathic pain disorders.

Authors:  B G Almay; L von Knorring; L Oreland
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

3.  Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia.

Authors:  J Fang; P H Yu; J W Gorrod; A A Boulton
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

4.  Molecular properties of monoamine oxidases A and B.

Authors:  S W Kwan; J M Bergeron; C W Abell
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?

Authors:  A Fleissner; R Seifert; K Schneider; W Eckert; B Fuisting
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

6.  Discrimination of idiopathic pain syndromes from neurogenic pain syndromes and healthy volunteers by means of clinical rating, personality traits, monoamine metabolites in CSF, serum cortisol, platelet MAO and urinary melatonin.

Authors:  L von Knorring; B G Almay; J Häggendal; F Johansson; L Oreland; L Wetterberg
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986

Review 7.  Idiopathic pain and depression.

Authors:  L von Knorring; L Ekselius
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.